Playing Games in the Prescription Drug Market: Cost Implications and Legal Solutions

Panel talk brought to you by the Health Policy and Bioethics Consortium.

High drug prices increase health care spending and cause substantial stress on patients. An important antidote to high prices is the introduction of low-cost generic drugs. However, brand-name drug manufacturers have employed various strategies to delay generic entry and undermine price competition, from forcing patients to switch to new formulations to transferring their patients to Native American tribes. What are the ethical implications of these strategies? What is their economic toll? How can we change the law to ensure that the generic drug market remains effective in delivering low-cost options for drugs and biologics?

RSVP here.